Seasonality in Down's syndrome. An endocrinological explanation

An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.

British journal of cancer·2007

Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.

The journal of peptide research : official journal of the American Peptide Society·2004

Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.

The journal of peptide research : official journal of the American Peptide Society·2001

Sex of first child and breast cancer survival in young women.

Journal of women's health & gender-based medicine·2001

Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties.

The journal of peptide research : official journal of the American Peptide Society·2001

Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs.

The journal of peptide research : official journal of the American Peptide Society·2001

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Roles of microRNA in aging and dietary restriction-induced longevity.

Frontiers in genetics·2026

Decoding immunoglobulin repertoires in zebrafish reveals distinct paradigms for adaptive immune diversification in ancient vertebrates.

Journal of genetics and genomics = Yi chuan xue bao·2026

Dioscin extends lifespan and ameliorates aging associated phenotypes in association with the endoplasmic reticulum unfolded protein response.

Experimental gerontology·2026

Alterations of actin in aging.

Journal of cell science·2026

Nutrient/TOR signaling controls adipose mitochondrial transcription factor A (TFAM) to regulate organismal growth in Drosophila.

FEBS letters·2026

Detailed study of bifurcations in a rate model with excitatory and inhibitory neurons and adaptation.

Journal of computational neuroscience·2026

Related Experiment Videos

Seasonality in Down's syndrome. An endocrinological explanation

Related Concept Videos

An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.

Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.

Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.

Sex of first child and breast cancer survival in young women.

Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties.

Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Roles of microRNA in aging and dietary restriction-induced longevity.

Decoding immunoglobulin repertoires in zebrafish reveals distinct paradigms for adaptive immune diversification in ancient vertebrates.

Dioscin extends lifespan and ameliorates aging associated phenotypes in association with the endoplasmic reticulum unfolded protein response.

Alterations of actin in aging.

Nutrient/TOR signaling controls adipose mitochondrial transcription factor A (TFAM) to regulate organismal growth in Drosophila.

Detailed study of bifurcations in a rate model with excitatory and inhibitory neurons and adaptation.

Related Experiment Videos

Seasonality in Down's syndrome. An endocrinological explanation

Related Concept Videos

Related Articles